Exiqon
Home Search Contact Print Mobile Sign In
 
 
Products Services Applications Resource Center Ordering About Exiqon Investor
microRNA Research
RNA Research
DNA Research
Custom Oligos
Other Reagents
RNA Isolation
Microarray Analysis
Real-time PCR
Northern Blotting
In Situ Hybridization
Functional Analysis
RNA Preparation
Microarray analysis
Real-time PCR
In Situ Hybridization
Antisense
SNP Detection
Microarray Analysis
In Situ Hybridization
LNA Phosphoramidites
AQ-link Products
A2 Quencher
RNA Isolation Services
microRNA Array Services
microRNA PCR Services
microRNA ISH Services
Isolation
Microarray Analysis
Northern Blotting
Real-time PCR
In Situ Hybridization
Functional Analysis
SNP Detection
RNA
microRNA
RNA
DNA
microRNA
microRNA
mRNA
microRNA
Other RNAs
DNA
microRNA
RNA
DNA
MicroRNA Research
RNA Research
Other reagents
Technology Base
Oligo design tools
Exiqon E-talk
Research Guide
Array Downloads
qPCR Data Analysis
Technical Literature and Manuals
Scientific Publications
Application Stories
Bioinformatics
Technical Literature and Manuals
Scientific Publications
Application Stories
Bioinformatics
Technical Literature and Manuals
Scientific Publications
Oligo modifications
LNA™
AQ-link
Order microRNA products
Order custom oligos
Distributors
General Information
Contact
Company profile
Sign up to Newsletter
Newsletter Back Issues
Investor Relations
Media
Announcements
Financials
Guidelines for Incentive Pay
Corporate Governance
Investor Signup
Contact Us
Share Info
Calendar
Reports
Figures
Analysts
Presentations
Contact
Tal og fakta
Samarbejdspartnere
IR Policy
Articles of Association
 

Corporate Governance

Exiqon A/S is subject to recommendations on corporate governance which are available on the Committee on Corporate Governance's website www.corporategovernance.dk. Reference is made to the Committee on Corporate Governance's recommendations of 8 April 2010 which NASDAQ OMX Copenhagen A/S has also decided to include in its Rules for issuers.


Further information is available in the annual corporate governance statement, cf. Section 107b of the Danish Financial Statement Act covering the financial period 1 January to 31 December 2010 at: www.exiqon.com/investor/corporategovernance/2010.

Supervisory Board

All Board members elected by the Annual General Meeting are up for election each year.


Procedures and guidelines for Exiqon’s management reporting to the Supervisory Board and for the mutual communication between the Supervisory Board and the Management are described in the Board’s rules of procedure which also include a fixed calendar of meetings to ensure that the Supervisory Board observes its duties.


The Supervisory Board of Exiqon A/S must have a sound general commercial understanding of the business and markets in which the company operates to best perform its task, including without limitation, commercial and financial skills, market understanding and entrepreneurship.

Board committees

Exiqon uses board committees, and the Supervisory Board has created two board committees: an audit committee and a compensation committee. The audit committee assists the Supervisory Board in its oversight with the company's annual and interim financial reporting including accounting policies and internal controls. The compensation committee advises the Supervisory Board on remuneration of employees and Executive Management including incentive schemes. Material decisions are always made by all members of the Supervisory Board, and all members of the Supervisory Board are informed of all decisions.

Corporate governance rules referred to in:

Annual Report 2010

Regler for selskabsledelse refereret til i:

Årsrapport 2010

  Privacy   Sitemap   Legal